Qiagen gets key nucleic-acid patients:
This article was originally published in Clinica
Executive Summary
Qiagen has acquired licensing rights to Iowa Biotechnology's key and pending patents covering purification and stabilization of DNA and RNA samples using cationic detergents. The acquisition is intended to strengthen Qiagen's position in the market for nucleic acid purification, particularly its sales to blood banks and in the diagnosis of infectious diseases.